Synovo Group secures €13 million to fuel international expansion and AI development
Synovo Group, a leading software provider for the healthcare transportation sector, has announced a €13 million Series A funding round led by Lauxera Capital Partners. This strategic investment will enable the Strasbourg-based company to accelerate its international expansion, particularly into English-speaking markets, and to further develop its proprietary artificial intelligence technology.
A Strategic Investment for Growth
Founded in 2012 by visionary entrepreneurs Jérémy Wies, Michel Lacombe, and Guillaume Philipp, Synovo Group has become a key player in the digital services and software solutions industry for healthcare transportation. The company’s comprehensive offerings include software for private ambulance operators, non-emergency medical transportation (NEMT), and patient mobility management within hospitals. Their solutions manage over 4,000 vehicles daily, covering approximately 20% of the market, with a team of over 100 employees spread across France and Canada.
With this new injection of capital, Synovo Group is set to reinforce its growth strategy. The funding will not only support the company’s expansion into international markets but also bolster its innovation efforts, particularly in the development of an AI system designed to optimize real-time ambulance transportation flows. Additionally, Synovo plans to introduce a new module focused on comprehensive cost management and environmental performance.
“We are thrilled to welcome Lauxera, an investor with deep expertise in health technologies, as a strategic partner in our growth journey,” said Jérémy Wies, co-founder and CEO of Synovo Group. “With these additional resources, we aim to accelerate our acquisition ambitions and continue to develop Synovo in France, Canada, and internationally. Our upcoming modules, leveraging our proprietary development capabilities and customer-centric approach, will continue to add value for our clients, helping them better support patients and hospitals.”
Synovo’s Commitment to Innovation and Excellence
Synovo Group’s commitment to innovation is reflected in its continuous development of cutting-edge software solutions tailored to the needs of the healthcare transportation sector. The company is ISO 27001 and HDS (Health Data Hosting) certified, ensuring the confidentiality, integrity, and availability of the data hosted on its servers. These certifications are a testament to Synovo’s dedication to maintaining the highest standards of data security and privacy for its clients.
The company’s software solutions are integral to the efficient deployment of patient transportation, a critical component of healthcare systems that ensures patients can access care from their homes to clinics, outpatient centers, and hospitals. By harnessing advanced algorithms and AI technology, Synovo’s products are highly regarded in the industry, contributing to a more sustainable and efficient healthcare system.
A Strategic Partnership for Global Reach
Victor Decrion, Managing Partner at Lauxera Capital Partners, expressed enthusiasm for the partnership: “It is an honor to collaborate with the highly talented founders of Synovo and to have the opportunity to support the company’s growth. Their solutions are not only recognized by their clients but also have a positive impact on healthcare systems, patients, payers, and healthcare transportation professionals. Their highly innovative solutions have the potential to be commercialized globally, and we look forward to supporting the company during this phase of expansion.”
This investment marks the twelfth and final investment by Lauxera Growth I, a growth and buyout fund dedicated primarily to European health tech companies in their commercial phase. Lauxera Capital Partners, with offices in Paris and San Francisco, is an independent asset management firm specializing in health technologies. Their investment in Synovo Group aligns with their mission to promote the growth of Europe’s most promising health tech innovations.
